Drugs Brain and Behavior (DDP)
Early Phase 1
Completed
- Conditions
- Stimulant Use
- Interventions
- Drug: placebo oral tablet
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 138
- Registration Number
- NCT04642820
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric Surgery
Not Applicable
Recruiting
- Conditions
- Bariatric Surgery Candidate
- Interventions
- Other: Special diet
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 28
- Registration Number
- NCT04590690
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Genicular Artery Embolization to Reduce Pain Associated With Unilateral Mild to Moderate Osteoarthritis
Not Applicable
Completed
- Conditions
- Knee Osteoarthritis
- Interventions
- Device: the Terumo Hydropearl® microspheres device
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 5
- Registration Number
- NCT04592562
- Locations
- 🇺🇸
University of Chicago Hospital, Chicago, Illinois, United States
Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
Phase 1
Completed
- Conditions
- Oropharyngeal Squamous Cell Carcinoma
- Interventions
- Other: Transoral Robotic Surgery (TORS) or RadiotherapyOther: Chemotherapy and Low-Dose RadiotherapyOther: Chemotherapy and High-Dose Radiotherapy
- First Posted Date
- 2020-10-01
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 50
- Registration Number
- NCT04572100
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes
Active, not recruiting
- Conditions
- Critical IllnessMicrobiome
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 500
- Registration Number
- NCT04552834
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Not Applicable
Recruiting
- Conditions
- Gastrointestinal CancerUGT1A1 Gene MutationHead and Neck CancerDihydropyrimidine Dehydrogenase DeficiencyBreast Cancer
- Interventions
- Other: Availability of clinical decision support based on pharmacogenomic results.
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 860
- Registration Number
- NCT04541381
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Olaparib in Patients With HRD Malignant Mesothelioma
Phase 2
Recruiting
- Conditions
- MesotheliomaHomologous Recombination Deficiency
- Interventions
- First Posted Date
- 2020-08-17
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 56
- Registration Number
- NCT04515836
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Ambulation With Labor Epidural in Obese Women
Not Applicable
Terminated
- Conditions
- Labor Onset and Length AbnormalitiesObesity
- Interventions
- Behavioral: Ambulation
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 14
- Registration Number
- NCT04504682
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Comprehensive Care Community and Culture Study
Not Applicable
Recruiting
- Conditions
- Quality of CareCost of CareComprehensive CareMedicare
- Interventions
- Behavioral: Comprehensive Care Physician Program (CCP)Behavioral: Ambulatory Care Coordinator Team (ACCT)Behavioral: Comprehensive Care Community & Culture Program (C4P)
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 3000
- Registration Number
- NCT04489693
- Locations
- 🇺🇸
David Meltzer, Chicago, Illinois, United States
Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19
Phase 2
Active, not recruiting
- Conditions
- COVID-19
- Interventions
- Other: Standard of Care
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 75
- Registration Number
- NCT04479358
- Locations
- 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath